InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,732.93
(
0.25%
)
US TECH 100
19,414.80
(
0.00%
)
Dow Jones
42,208.22
(
0.20%
)
Brent Oil
74.24
(
-0.44%
)
Bitcoin
63,859.41
(
-0.64%
)
Post# of 253213
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 839
Posts 120491
Boards Moderated 18
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biotech_researcher post# 207796

Monday, 01/09/2017 2:51:55 PM

Monday, January 09, 2017 2:51:55 PM

Post# of 253213

ADXS—In general, I stay far and wide away from companies that have THAT many irons in the fire at such an early stage in their life.

That’s my general investing philosophy too, but I’ve made an exception with ADXS because: they are well-funded and reasonably disciplined in expense control (#msg-127726151); all of the programs are based on a shared technology platform; and there are partnerships with AMGN, AZN, and MRK to confer some validation for what ADXS is doing.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up